← Back to Search

Phone-Based Support Sessions for Breast Cancer

N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights

Study Summary

This trial will examine if 3 phone-based sessions can help Latina women with genetic and social risk factors.

Who is the study for?
This trial is for Latina women over 30 years old who have a personal or family history of breast or ovarian cancer and face social challenges affecting their health. They must not have had genetic counseling or testing for cancer, and should be eligible for breast cancer screenings based on guidelines.Check my eligibility
What is being tested?
The study tests an empowerment and navigation intervention to help Latinas access breast cancer care. Participants will receive three phone sessions with the study team over consecutive weeks to support them in managing their health risks.See study design
What are the potential side effects?
Since this trial focuses on educational and navigational interventions rather than medical treatments, there are no direct side effects like those associated with drugs or surgeries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Empower and navigation versus SOC

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
Standard of Care (SOC)
Group II: Arm 1Experimental Treatment1 Intervention
Empowerment and Navigation

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
609 Previous Clinical Trials
1,558,709 Total Patients Enrolled
10 Trials studying Breast Cancer
1,341,756 Patients Enrolled for Breast Cancer

Media Library

Empowerment and Navigation Clinical Trial Eligibility Overview. Trial Name: NCT05483283 — N/A
Breast Cancer Research Study Groups: Arm 2, Arm 1
Breast Cancer Clinical Trial 2023: Empowerment and Navigation Highlights & Side Effects. Trial Name: NCT05483283 — N/A
Empowerment and Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05483283 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity for individuals to join this research?

"Affirmative. Clinicaltrials.gov confirms that this medical study is still accepting participants, which were initially recruited on January 18th 2023 and the listing was last modified on May 18th 2023. The trial currently seeks 220 individuals at a single location."

Answered by AI

How many participants are being accepted into this research endeavor?

"Affirmative. Clinicaltrials.gov states that this medical trial is currently recruiting members, with its original posting date being January 18th 2023 and last update on May 18th of the same year. The clinical trial requires 220 participants to be enrolled from a single location."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
Yamile Molina 2023. "Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05483283.
~400 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top